Higuchi John W. bought 15,970 shares of Lipocine Inc. at $2.23 for $35.6k on Sep 30, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Oct 1, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$35,613.10Shares × reported price
Shares traded
15,970Common stock
Price per share
$2.23Reported price. Read footnotes for ranges.
% of reported position traded
7.09%This security and ownership context
Holdings after
241,365Direct
Trade date
Sep 30, 2026Buy
Filed
Oct 1, 2026, 8:28 PM ET2-day reporting delay
Accession
0001493152-26-045400Code P · Transaction 233563
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 225,395 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 29, 2026Buy9,037$2.15$19,429.55Trade 233562
2 transaction rows in this filing. Joint filers share the same rows.

LPCN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
LPCN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +9.3%1w ago +3.4%1d ago +5.4%
Returns since7d −16%30d −30%90d180d1y

Footnotes in full

No footnotes recorded. Check the original SEC filing for the complete report.